Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Assertio Therapeutics ( (ASRT) ) has shared an announcement.
On April 21, 2026, Assertio announced that Garda Therapeutics plans to launch a tender offer on April 29, 2026 to acquire all outstanding Assertio shares, following the expiration of a 20‑day “window‑shop” period. The move follows a definitive April 8, 2026 agreement under which Garda will pay $18.00 per share in cash, valuing the deal at about $125.1 million plus a contingent value right.
During the 20‑day window‑shop period, Assertio is permitted to engage with alternative bidders that could deliver superior value to shareholders, with any board-approved switch triggering a reduced breakup fee. The structure underscores competitive tension around Assertio’s oncology-focused portfolio and gives investors a defined timetable and optionality ahead of the planned tender launch.
The most recent analyst rating on (ASRT) stock is a Hold with a $18.05 price target. To see the full list of analyst forecasts on Assertio Therapeutics stock, see the ASRT Stock Forecast page.
Spark’s Take on ASRT Stock
According to Spark, TipRanks’ AI Analyst, ASRT is a Neutral.
The score is held back primarily by weak financial performance, including declining revenue, recurring losses, and newly negative operating/free cash flow. Offsetting factors include strong technical momentum, a constructive earnings outlook with higher 2026 EBITDA guidance, and significant event-driven support from the announced all-cash acquisition.
To see Spark’s full report on ASRT stock, click here.
More about Assertio Therapeutics
Assertio Holdings, Inc. is a pharmaceutical company with commercial capabilities focused on marketing differentiated therapies, primarily in the oncology market. The company concentrates on addressing patients’ needs through its specialty drug portfolio and operates as a Nasdaq-listed issuer under the ticker ASRT.
Average Trading Volume: 113,846
Technical Sentiment Signal: Hold
Current Market Cap: $116.1M
See more insights into ASRT stock on TipRanks’ Stock Analysis page.